You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Positron Emission Tomography (PET)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venous Thromboembolism (VTE) Trial (Additional blood sampling)

Not yet recruiting
  • Venous Thromboembolism (VTE)
  • Additional blood sampling
  • (no location specified)
Sep 26, 2023

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

Parkinson Disease Trial in Toulouse (Clinical assessment, Pain characteristics assessment, MRI)

Not yet recruiting
  • Parkinson Disease
  • Clinical assessment
  • +5 more
  • Toulouse, Haute-Garonne, France
    Centre Hospitalier Universitaire de Toulouse
Aug 22, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)

Recruiting
  • Pancreatic Cancer
  • Cholangiocarcinoma
  • [68Ga]Ga-FAPI-46 PET/CT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Jul 13, 2023

Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (FNP-59)

Recruiting
  • Radiotracer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan
Dec 9, 2022

Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

Active, not recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jan 17, 2023

Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Prostate Cancer
  • Localized Prostate Carcinoma
  • PSMA-1007 Positron Emission Tomography (PET) scan
  • (no location specified)
Aug 14, 2023

Simultaneous Fluorodeoxyglucose Positron Emission Tomography and

Completed
  • Visual Snow Syndrome
  • simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)
  • (no location specified)
Jan 26, 2023

Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with

Recruiting
  • Radiotracer
  • +2 more
  • Dexamethasone (Group 2)
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan
Dec 9, 2022

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

Sickle Cell Disease Trial (Positron Emission Tomography, Cu-64]-LLP2A)

Recruiting
  • Sickle Cell Disease
  • Pittsburgh, Pennsylvania
    UPMC
Dec 2, 2022

Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))

Not yet recruiting
  • Prostate Cancer
  • Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
  • (no location specified)
Jan 26, 2023

Prostate Cancer Trial in Edmonton (PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI))

Recruiting
  • Prostate Cancer
  • PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
  • Edmonton, Alberta, Canada
    University of Alberta
Jan 9, 2023

Cancer Trial in Stanford (68Ga-FAPI, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Cancer
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 9, 2022

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)

Active, not recruiting
  • Prostatic Neoplasms
  • 18F- DCFPyL PET/CT
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

Recruiting
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2022

Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,

Not yet recruiting
  • Cancer Head Neck
  • +2 more
  • adnectin 18F-BMS-986192 Head and Neck Cancer
  • adnectin 18F-BMS-986192 Brain Metastases
  • New Haven, Connecticut
    Yale University PET Center
Oct 10, 2022

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's

Recruiting
  • Alzheimer Disease
  • Healthy
  • Positron Emission Tomography (PET) using two PET tracer under IND
  • Houston, Texas
    Houston Methodist Research Institute
Jan 20, 2023

PET Scanning in Parkinson s Disease

Recruiting
  • Schizophrenia
  • Parkinson's Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Positron Emission Tomography Imaging in People With Gaucher

Completed
  • Parkinson Disease
  • Gaucher Disease
  • 15-0 H20
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2023